Net Income (Annual) Chart

View Net Income (Annual) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
December 31, 2025 263.86M
December 31, 2024 -88.88M
December 31, 2023 -226.54M
December 31, 2022 -247.12M
December 31, 2021 -184.06M
December 31, 2020 -182.81M
December 31, 2019 -108.90M
December 31, 2018 -101.25M
December 31, 2017 -65.78M
December 31, 2016 -55.14M
December 31, 2015 -43.02M
December 31, 2014 -45.19M
December 31, 2013 -30.11M
December 31, 2012 -39.08M
December 31, 2011 -56.95M
December 31, 2010 -33.85M
Date Value
December 31, 2009 -13.45M
December 31, 2008 -24.73M
December 31, 2007 -29.06M
December 31, 2006 -43.62M
December 31, 2005 -26.10M
December 31, 2004 -21.10M
December 31, 2003 -12.70M
December 31, 2002 -16.93M
December 31, 2001 -4.986M
December 31, 2000 -5.490M
December 31, 1999 -5.298M
December 31, 1998 -4.785M
December 31, 1997 -10.62M
December 31, 1996 -7.698M
December 31, 1995 -8.576M
December 31, 1994 -6.938M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Amgen, Inc. 7.711B
Vertex Pharmaceuticals, Inc. 3.953B
Agenus, Inc. -3.083M
Anika Therapeutics, Inc. -9.979M
Imunon, Inc. -14.50M